U.S. Stops Funding for Gavi Global Vaccine Program, Sparking Backlash

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 27, 2025.

via HealthDay

FRIDAY, June 27, 2025 — The United States will stop sending money to Gavi, a global group that helps vaccinate children in low-income countries, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said Wednesday.

The decision was made public in a video shared at a Gavi summit in Brussels. In it, Kennedy said Gavi has not done enough to address vaccine safety — though he gave no proof of that claim, The Washington Post said in a report.

“When vaccine safety issues have come before Gavi, Gavi has treated them not as a patient health problem, but as a public relations problem,” Kennedy said.

He also referenced a study suggesting the DTP vaccine — which protects against diphtheria, tetanus and pertussis — may raise the risk of child death. But Gavi strongly denied that claim.

The group said it has full confidence in the DTP vaccine, which has played a major role in reducing child deaths in the countries it helps.

“In places where access to hospitals is limited and disease risk is high, the stronger protection from DTwP against these life-threatening diseases far outweighs the temporary side-effects this vaccine may cause," Gavi said in a statement.

Gavi is a public-private alliance that has helped vaccinate more than 1.1 billion children in 78 countries since 2000, preventing an estimated 18.8 million future deaths, The Post said.

The group supports vaccines for about 20 infectious diseases, including measles, malaria, HPV and Ebola.

With a large demand for vaccines, Gavi works with manufacturers to secure lower prices and helps countries pay for those doses.

The United States was Gavi’s third-largest donor, providing about 12% of the group’s funding last year, right behind the United Kingdom and the Gates Foundation.

Kennedy’s announcement was met with harsh criticism from health officials.

“The RFK decision will cause children to die,” Prabhat Jha, a professor in global health and epidemiology at the University of Toronto Dalla Lana School of Public Health, said in an email to The Post.

Atul Gawande, former head of global health at the U.S. Agency for International Development, called the decision a “travesty and a nightmare.”

“This pull out will cost 100s of thousands of children’s lives a year — and RFK Jr. will be personally responsible,” he wrote.

Bill Gates, whose foundation helped create Gavi, asked Congress to reverse the decision, saying it would lead to “devastating consequences: more sick kids who fall behind in school, more overcrowded hospital wards, and eventually more grieving parents.”

Still, other countries stepped up. At Wednesday’s summit, donors pledged more than $9 billion to Gavi. The Gates Foundation alone committed $1.6 billion.

A study funded by Gavi and published in The Lancet this week warned that while the World Health Organization’s (WHO) vaccine efforts have saved millions of lives, progress is stalling.

The reasons include poor access, the COVID-19 pandemic and a lot of vaccine misinformation.

Kennedy recently reshaped the U.S. vaccine advisory board. He fired all 17 staff members from the committee that helps set vaccine rules for the CDC and replaced them with eight new members, some of whom were anti-vaccine advocates.

The new group plans to review the childhood vaccine schedule and rethink hepatitis B vaccine guidelines, The Post said.

Sources

  • The Washington Post, June 26, 2025
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords